# BSP Pharmaceuticals SpA, Latina, Italy – FDA Inspections

Source: https://www.keypedia.com/companies/bsp-pharmaceuticals-spa/cbf52ec3-50e2-4cf1-9f81-f0f7a74473fc

> Inspection records and compliance data for BSP Pharmaceuticals SpA in Latina. 8 FDA inspections on record, 3 Form 483s, last inspected February 29, 2024.

---

## Details

- Name: BSP Pharmaceuticals SpA
- FEI Number: 3007255826
- Business Operations: API MANUFACTURE
- Address Line 1: Via Appia Km 65,561
- City: Latina
- Country Name: Italy
- Address: Via Appia Km 65,561, Latina, Italy
- Country: Italy

## Related Documents

- [483 - BSP Pharmaceuticals SpA - Unknown Date](https://www.keypedia.com/records/483/bsp-pharmaceuticals-spa/6d9334e4-355f-4e21-ad72-92357fb9a296) — source: FDA, date: Invalid Date
- [483 - BSP Pharmaceuticals SpA - 2026-09-08](https://www.keypedia.com/records/483/bsp-pharmaceuticals-spa/db79cefd-005f-4995-ae45-d358ec8dbf58) — source: FDA, date: September 8, 2026
- [483 - BSP Pharmaceuticals SpA - 2024-02-29](https://www.keypedia.com/records/483/bsp-pharmaceuticals-spa/46658879-500e-4fe3-a530-e8b26729b86a) — source: FDA, date: February 29, 2024
- [FDA Inspection 1232171 - BSP Pharmaceuticals SpA - 2024-02-29](https://www.keypedia.com/records/fda_inspections/bsp-pharmaceuticals-spa/3b6d1849-e7b8-40f9-96cc-4e6bb3d55d8c) — source: FDA, date: February 29, 2024
- [483 - BSP Pharmaceuticals SpA - 2022-03-23](https://www.keypedia.com/records/483/bsp-pharmaceuticals-spa/3c1888ce-6dae-4af7-9cc7-89243028fb7e) — source: FDA, date: March 23, 2022
- [FDA Inspection 1172555 - BSP Pharmaceuticals SpA - 2021-11-12](https://www.keypedia.com/records/fda_inspections/bsp-pharmaceuticals-spa/ab1fa615-f7d5-446f-8627-7b386db151d7) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 12, 2021
- [FDA Inspection 1071722 - BSP Pharmaceuticals SpA - 2018-09-21](https://www.keypedia.com/records/fda_inspections/bsp-pharmaceuticals-spa/bf14bd98-e87e-47fb-b46f-59c1a4683aeb) — source: FDA, date: September 21, 2018
- FDA Inspection 1091112 - BSP Pharmaceuticals SpA - 2017-10-20 — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 20, 2017
- [FDA Inspection 1016102 - BSP Pharmaceuticals SpA - 2016-12-16](https://www.keypedia.com/records/fda_inspections/bsp-pharmaceuticals-spa/dbd27341-8470-41b0-8ef0-5e3534fc848e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 16, 2016
- [483 - BSP Pharmaceuticals SpA - 2016-12-08](https://www.keypedia.com/records/483/bsp-pharmaceuticals-spa/c8fc4c30-55b3-4faf-9131-aec2c37cf504) — source: FDA, date: December 8, 2016
- [FDA Inspection 935609 - BSP Pharmaceuticals SpA - 2015-06-26](https://www.keypedia.com/records/fda_inspections/bsp-pharmaceuticals-spa/14269f8f-2bbb-49d1-baef-69ba82aa95d2) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 26, 2015
- FDA Inspection 811321 - BSP Pharmaceuticals SpA - 2012-12-05 — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 5, 2012
- FDA Inspection 698052 - BSP Pharmaceuticals SpA - 2010-11-12 — classification: No Action Indicated (NAI), source: FDA, date: November 12, 2010

## Related Companies

- [Avista Pharma Solutions, Inc. dba Cambrex](https://www.keypedia.com/companies/avista-pharma-solutions-inc-dba-cambrex/ca9e4205-cd7f-44bd-8dbe-a9d98be57047)
- [Alexion Pharma International Operations Unlimited Co.](https://www.keypedia.com/companies/alexion-pharma-international-operations-unlimited-co/7c523c79-b4b1-4a47-8393-141753fd60e8)
- [Abbvie Biotechnology Ltd.](https://www.keypedia.com/companies/abbvie-biotechnology-ltd/b438b15a-033c-469a-8973-66b6506bba41)
- [Boehringer Ingelheim Biopharmaceuticals (China) Ltd.](https://www.keypedia.com/companies/boehringer-ingelheim-biopharmaceuticals-china-ltd/be450a8b-4f71-4f06-96b3-908a2ed1b580)
- [Sun Pharmaceutical Medicare Limited](https://www.keypedia.com/companies/sun-pharmaceutical-medicare-limited/bcde6f4d-9644-445c-b813-cb49ed881f97)
- [Wacker Biotech B.V.](https://www.keypedia.com/companies/wacker-biotech-bv/9bd47c05-6585-4710-a9ea-4bd04e15dd4f)
- [Genzyme Corporation](https://www.keypedia.com/companies/genzyme-corporation/b597b205-d758-426b-bc64-09970b3a1b83)
- [Regeneron Pharmaceuticals Inc](https://www.keypedia.com/companies/regeneron-pharmaceuticals-inc/cd765cfa-95e6-4023-ade2-0ffa382fe2c7)
- [Hovione LLC](https://www.keypedia.com/companies/hovione-llc/06b4417a-5377-4e73-8076-71d3066fa8f0)
- [Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/second-tokushima-factory-otsuka-pharmaceutical-co-ltd/d07820ec-a994-41cb-b667-509183a6cc4a)

## Related Officers

- [Investigator/Consumer Safety Officer](https://www.keypedia.com/people/francis-a-guidry/fd6d2a17-7f94-4f7c-8284-ad1f07d703e9)
- [Xiaokuang Lai](https://www.keypedia.com/people/xiaokuang-lai/6c25851d-0954-4f42-8f14-c2e0382e6815)
- [investigator](https://www.keypedia.com/people/reyes-candau-chacon/f45d84c3-da5c-4958-bee8-084883ce8fef)
- [Jessica Hankins](https://www.keypedia.com/people/jessica-hankins/199a210e-6fa6-4d96-928d-4eee36658454)
- [ Investigator, Consumer Safety Officer](https://www.keypedia.com/people/thuy-t-nguyen/1cfb5467-f0b7-49b8-85c1-00373692e35e)
- [Compliance Officer](https://www.keypedia.com/people/yasamin-ameri/73021772-c960-4c65-aa30-cb490866ee58)